Who
Solomon Moshkevich
President, Clinicaldiagnostics
Company insider
Files Form 4 as: President, Clinicaldiagnostics, Natera.
In numbers
- Trades disclosed
- 214
- Buys
- 0
- Sells
- 59
- Bought
- $0
- Sold
- $63.5M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 26 Jan 2024
- Last trade
- 1 Oct 2026
- Last filed
- 2 Oct 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 1 Oct 2026filed 2 Oct 2026 | NTRA NateraDiagnostics & Labs | SEC FORM 4 Sold | $82K200 at $411.62 | filing |
| 1 Oct 2026filed 2 Oct 2026 | NTRA NateraDiagnostics & Labs | SEC FORM 4 Sold | $394K954 at $413.11 | filing |
| 1 Oct 2026filed 2 Oct 2026 | NTRA NateraDiagnostics & Labs | SEC FORM 4 Sold | $766K1,846 at $415.07 | filing |
| 16 Sep 2026filed 18 Sep 2026 | NTRA NateraDiagnostics & Labs | SEC FORM 4 Code G | —945 at $0.00 | filing |
| 16 Sep 2026filed 18 Sep 2026 | NTRA NateraDiagnostics & Labs | SEC FORM 4 Code G | —945 at $0.00 | filing |
| 2 Sep 2026filed 3 Sep 2026 | NTRA NateraDiagnostics & Labs | SEC FORM 4 Sold | $5.0M15,160 at $326.89 | filing |
| 2 Sep 2026filed 3 Sep 2026 | NTRA NateraDiagnostics & Labs | SEC FORM 4 Sold | $5.0M15,160 at $326.89 | filing |
| 1 Sep 2026filed 3 Sep 2026 | NTRA NateraDiagnostics & Labs | SEC FORM 4 Sold | $320K1,000 at $319.76 | filing |
| 1 Sep 2026filed 3 Sep 2026 | NTRA NateraDiagnostics & Labs | SEC FORM 4 Sold | $449K1,400 at $320.92 | filing |
| 1 Sep 2026filed 3 Sep 2026 | NTRA NateraDiagnostics & Labs | SEC FORM 4 Sold | $193K600 at $321.91 | filing |
| 1 Sep 2026filed 3 Sep 2026 | NTRA NateraDiagnostics & Labs | SEC FORM 4 Sold | $320K1,000 at $319.76 | filing |
| 1 Sep 2026filed 3 Sep 2026 | NTRA NateraDiagnostics & Labs | SEC FORM 4 Sold | $449K1,400 at $320.92 | filing |
| 1 Sep 2026filed 3 Sep 2026 | NTRA NateraDiagnostics & Labs | SEC FORM 4 Sold | $193K600 at $321.91 | filing |
| 3 Aug 2026filed 5 Aug 2026 | NTRA NateraDiagnostics & Labs | SEC FORM 4 Sold | $110K410 at $267.99 | filing |
| 3 Aug 2026filed 5 Aug 2026 | NTRA NateraDiagnostics & Labs | SEC FORM 4 Sold | $78K300 at $259.98 | filing |
| 3 Aug 2026filed 5 Aug 2026 | NTRA NateraDiagnostics & Labs | SEC FORM 4 Sold | $52K200 at $261.49 | filing |
| 3 Aug 2026filed 5 Aug 2026 | NTRA NateraDiagnostics & Labs | SEC FORM 4 Sold | $250K947 at $263.94 | filing |
| 3 Aug 2026filed 5 Aug 2026 | NTRA NateraDiagnostics & Labs | SEC FORM 4 Sold | $51K192 at $265.28 | filing |
| 3 Aug 2026filed 5 Aug 2026 | NTRA NateraDiagnostics & Labs | SEC FORM 4 Sold | $330K1,233 at $267.79 | filing |
| 3 Aug 2026filed 5 Aug 2026 | NTRA NateraDiagnostics & Labs | SEC FORM 4 Sold | $34K128 at $268.70 | filing |
News
Natera (NASDAQ:NTRA) Stock: Insider Solomon Moshkevich Sells 3,000 Sharesthemarketsdaily.com · 3 Oct 2026Financial Comparison: Valneva (NASDAQ:VALN) and Natera (NASDAQ:NTRA)NTRA · tickerreport.com · 22 Oct 2026Natera (NTRA) Is Expanding Cancer Testing Rapidly. Does Its Valuation Leave Room for Error?NTRA · insidermonkey.com · 20 Oct 2026ESMO 2026 Presentations Deepen the Evidence Base for Natera's Oncology Portfolio and Leadership in Ultrasensitive MRD Technology | wallstreetONLINENTRA · wallstreet-online.de · 19 Oct 2026
1 headline in the last 90 days name Solomon Moshkevich; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.